ロード中...
PML-IRIS during Fingolimod Diagnosed after Natalizumab Discontinuation
Background. Natalizumab treatment is frequently discontinued and replaced by alternative medication in multiple sclerosis (MS) patients having a high risk of progressive multifocal leukoencephalopathy (PML). Case Presentation. We report a PML case that was missed on magnetic resonance imaging (MRI)...
保存先:
| 出版年: | Case Rep Neurol Med |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Hindawi Publishing Corporation
2014
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4258922/ https://ncbi.nlm.nih.gov/pubmed/25506447 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2014/307872 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|